Ghaem-Maghami S - Search Results

1

Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin.

Parente-Pereira AC, Whilding LM, Brewig N, van der Stegen SJ, Davies DM, Wilkie S, van Schalkwyk MC, Ghaem-Maghami S, Maher J. Parente-Pereira AC, et al. J Immunol. 2013 Sep 1;191(5):2437-45. doi: 10.4049/jimmunol.1301119. Epub 2013 Jul 29. J Immunol. 2013. PMID: 23898037

2

Immunology of uterine transplantation: a review.

Saso S, Ghaem-Maghami S, Chatterjee J, Brewig N, Ungar L, Smith JR, Del Priore G. Saso S, et al. Reprod Sci. 2012 Feb;19(2):123-34. doi: 10.1177/1933719111417887. Epub 2011 Dec 2. Reprod Sci. 2012. PMID: 22138547 Review.

3

Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?

van der Stegen SJ, Davies DM, Wilkie S, Foster J, Sosabowski JK, Burnet J, Whilding LM, Petrovic RM, Ghaem-Maghami S, Mather S, Jeannon JP, Parente-Pereira AC, Maher J. van der Stegen SJ, et al. J Immunol. 2013 Nov 1;191(9):4589-98. doi: 10.4049/jimmunol.1301523. Epub 2013 Sep 23. J Immunol. 2013. PMID: 24062490

4

Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer.

Maine CJ, Aziz NH, Chatterjee J, Hayford C, Brewig N, Whilding L, George AJ, Ghaem-Maghami S. Maine CJ, et al. Cancer Immunol Immunother. 2014 Mar;63(3):215-24. doi: 10.1007/s00262-013-1503-x. Epub 2013 Dec 3. Cancer Immunol Immunother. 2014. PMID: 24297569 Free PMC article.

5

Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2 T cells, potentiated by liposomal alendronic acid.

Parente-Pereira AC, Shmeeda H, Whilding LM, Zambirinis CP, Foster J, van der Stegen SJ, Beatson R, Zabinski T, Brewig N, Sosabowski JK, Mather S, Ghaem-Maghami S, Gabizon A, Maher J. Parente-Pereira AC, et al. J Immunol. 2014 Dec 1;193(11):5557-66. doi: 10.4049/jimmunol.1402200. Epub 2014 Oct 22. J Immunol. 2014. PMID: 25339667

6

Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing.

Teo PY, Yang C, Whilding LM, Parente-Pereira AC, Maher J, George AJ, Hedrick JL, Yang YY, Ghaem-Maghami S. Teo PY, et al. Adv Healthc Mater. 2015 Jun 3;4(8):1180-9. doi: 10.1002/adhm.201500089. Epub 2015 Apr 11. Adv Healthc Mater. 2015. PMID: 25866054

7

Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian Cancer.

Chatterjee J, Dai W, Aziz NHA, Teo PY, Wahba J, Phelps DL, Maine CJ, Whilding LM, Dina R, Trevisan G, Flower KJ, George AJT, Ghaem-Maghami S. Chatterjee J, et al. Clin Cancer Res. 2017 Jul 1;23(13):3453-3460. doi: 10.1158/1078-0432.CCR-16-2366. Epub 2016 Dec 16. Clin Cancer Res. 2017. PMID: 27986748 Free article.

8

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.

Whilding LM, Parente-Pereira AC, Zabinski T, Davies DM, Petrovic RMG, Kao YV, Saxena SA, Romain A, Costa-Guerra JA, Violette S, Itamochi H, Ghaem-Maghami S, Vallath S, Marshall JF, Maher J. Whilding LM, et al. Mol Ther. 2017 Jan 4;25(1):259-273. doi: 10.1016/j.ymthe.2016.10.012. Epub 2017 Jan 4. Mol Ther. 2017. PMID: 28129120 Free PMC article.

9

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.

Whilding LM, Parente-Pereira AC, Zabinski T, Davies DM, Petrovic RMG, Kao YV, Saxena SA, Romain A, Costa-Guerra JA, Violette S, Itamochi H, Ghaem-Maghami S, Vallath S, Marshall JF, Maher J. Whilding LM, et al. Mol Ther. 2017 Oct 4;25(10):2427. doi: 10.1016/j.ymthe.2017.09.018. Epub 2017 Sep 23. Mol Ther. 2017. PMID: 28958577 Free PMC article. No abstract available.

10

Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer.

Wahba J, Natoli M, Whilding LM, Parente-Pereira AC, Jung Y, Zona S, Lam EW, Smith JR, Maher J, Ghaem-Maghami S. Wahba J, et al. Cancer Immunol Immunother. 2018 Nov;67(11):1753-1765. doi: 10.1007/s00262-018-2199-8. Epub 2018 Aug 24. Cancer Immunol Immunother. 2018. PMID: 30167862 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters